Oncology

Oncology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
221-233 of 233 ARTICLES
https://doi.org/10.12688/f1000research.23469.1
Case Report metrics
Case Report: Metastatic breast cancer to the gallbladder
[version 1; peer review: 2 approved]
Peer Reviewers Giorgio Ercolani; Francesco Fleres
PUBLISHED 11 May 2020
https://doi.org/10.12688/f1000research.20509.2
Opinion Article metrics
Revised
How shall we treat locally advanced triple negative breast cancer?
[version 2; peer review: 2 approved]
Peer Reviewers Brian D. Lehmann; Bruna Cerbelli
LATEST VERSION PUBLISHED 04 May 2020
https://doi.org/10.12688/f1000research.21564.1
Research Article metrics
Over-expression of Ki-67 as a predictor of lymph node metastasis in penile cancer patients
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Juan Chipollini; Yudhistira Pradnyan Kloping and Wahjoe Djatisoesanto
  • Funder
  • Universitas Sumatera Utara
PUBLISHED 24 Apr 2020
https://doi.org/10.12688/f1000research.22996.1
Brief Report metrics
Expression and prognostic significance of MT1 isoforms in clear cell renal cell carcinoma
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Peng Guo; Leili Saeednejad Zanjani
  • Funders
  • Qingyuan People’s Hospital
  • Medical Elite Cultivation Program of Fujian
  • National Natural Science Foundation of China
PUBLISHED 23 Apr 2020
https://doi.org/10.12688/f1000research.22624.1
Opinion Article metrics
Cancer cachexia has many symptoms but only one cause: anoxia
[version 1; peer review: 1 approved, 1 not approved]
Peer Reviewers Marília Seelaender; Barry Laird
PUBLISHED 09 Apr 2020
https://doi.org/10.12688/f1000research.22941.1
Review metrics
Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis
[version 1; peer review: 3 approved]
Peer Reviewers Faisal Aljofi; Ambreen Rehman and Fatima Qadir; Ali Leghari
PUBLISHED 02 Apr 2020
https://doi.org/10.12688/f1000research.15728.3
Research Article metrics
Revised
Anti-Mullerian hormone levels in female cancer patients of reproductive age in Indonesia: A cross-sectional study
[version 3; peer review: 2 approved]
Peer Reviewers Nao Suzuki; Xiang-Xi (Mike) Xu
  • Funder
  • Universitas Indonesia
LATEST VERSION PUBLISHED 20 Feb 2020
https://doi.org/10.12688/f1000research.21584.2
Brief Report metrics
Revised
DNA methylation changes in biomarker loci occur early in cancer progression
[version 2; peer review: 2 approved]
Peer Reviewers Keith D. Robertson; Judd C. Rice
  • Funders
  • National Institutes of Health
  • University of Arizona Cancer Center
LATEST VERSION PUBLISHED 14 Feb 2020
https://doi.org/10.12688/f1000research.21481.1
Research Article metrics
Effects of ‎tamoxifen on the reproductive system of female breast cancer patients: an ultrasound-based cohort study
[version 1; peer review: 2 not approved]
Peer Reviewers Marian J E Mourits; Lisa Rydén
PUBLISHED 10 Feb 2020
https://doi.org/10.12688/f1000research.19260.1
Research Article metrics
Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden
[version 1; peer review: 2 approved]
Peer Reviewers Truls Bjerklund-Johansen; Shingo Yamamoto
  • Funders
  • Nationella Prostatacancerregistret
  • Landstinget Västernorrland
PUBLISHED 28 Jan 2020
https://doi.org/10.12688/f1000research.19298.2
Research Article metrics
Revised
Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Bernard L. Marini; Vinod Pullarkat; David J. Young
LATEST VERSION PUBLISHED 17 Jan 2020
https://doi.org/10.12688/f1000research.21804.1
Research Article metrics
Clinical trial
A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Lubna N. Chaudhary; Caroline Hamm
  • Funder
  • Eli Lilly and Company
PUBLISHED 06 Jan 2020
https://doi.org/10.12688/f1000research.16786.1
Study Protocol metrics
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
[version 1; peer review: 2 approved]
Peer Reviewers Kalkunte S. Srivenugopal; Frantz Rom Poulsen
  • Funders
  • Sahlgrenska Foundation
  • Nordic Cancer Union
  • AG Foundation
  • ALF agreement
  • Sahlgrenska University Hospital
  • The Swedish Society of Medicine
PUBLISHED 15 Nov 2018
221-233 of 233 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.